Clinical trial

Comparison of MRI Artificial Intelligence-guided cTB Versus Routine cTB in Prostate Cancer Diagnosis

NCT06392737

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2024-05-01

PhaseNA

Study timeline

Study start (actual)2024-05-01Date precision: day

Registry last updated2025-07-02

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

Interventions

MRI-AI guided cognitive prostate targeted biopsyPROCEDURE

Routine cognitive prostate targeted biopsyPROCEDURE

Sponsors & collaborators

Peking University First Hospitallead sponsor

Mapped research locations

BeijingBeijing Municipality, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06392737 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.